All Articles
Are iPSCs the Key to Treating Parkinson’s and Autoimmune Diseases?
iPSCs can replace dopamine neurons in Parkinson’s and generate regulatory immune cells for autoimmune diseases; trials show promise despite cost, survival, and safety challenges.
iPSC Clinical Trials: The Latest Breakthroughs in Stem Cell Research
Overview of global iPSC clinical trials — Parkinson’s, eye, spinal and fertility therapies; safety, manufacturing challenges, and cord-blood/tissue banking.
Beyond Cord Blood: Understanding Induced Pluripotent Stem Cells (iPSCs)
How iPSCs differ from cord blood, their medical uses and risks, and why banking cord blood now keeps options open for future iPSC therapies.
What Are iPSCs? The Future of Regenerative Medicine Explained
What are iPSCs and how they work: reprogrammed adult cells enabling personalized, embryo-free therapies, disease models, and future tissue repair.
How iPSC Therapies Are Changing the Landscape of Cell Treatment
iPSC therapies reprogram adult cells into personalized regenerative treatments, improve drug testing, and show why newborn stem cell banking matters.
Top Uses of Stem Cells in Family Medicine
How stem cell therapies are used in family medicine for tissue repair, wound healing, pain control, neurological and autoimmune care, and cord-blood banking.
Cord Blood for Sibling Transplants: How It Works
Step-by-step guide to sibling cord blood transplants: HLA matching, collection, processing, transplant, engraftment, recovery, and banking benefits.
How Stem Cells Support Personalized Medicine
How patient-derived stem cells enable disease modeling, drug testing, gene editing and regenerative therapies—and why newborn stem cell banking matters.
Emerging Stem Cell Therapies for Age-Related Diseases
How newborn stem cell banking, MSCs and exosome therapies repair tissues, reduce inflammation, and target age-related diseases like arthritis, Alzheimer's, and heart failure.